Caladrius Biosciences(CLBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CLBS Caladrius Biosciences

Market Closed 09-14 16:00:00 EDT

0.4264

+0.0000

0.00%

High0.4264	Low0.4264	Vol0.00
Open0.4264	D1 Closing0.4264	Amplitude0.00%
Mkt Cap1.72M	Tradable Cap1.68M	Total Shares4.04M
T/O14.19M	T/O Rate0.00%	Tradable Shares3.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CLBS","market":"US","secType":"STK","nameCN":"Caladrius Biosciences","latestPrice":0.4264,"timestamp":1663185600000,"preClose":0.4264,"halted":8,"volume":0,"delay":0,"floatShares":3944518,"shares":4038903,"eps":0,"marketStatus":"Market Closed","change":0,"latestTime":"09-14 16:00:00 EDT","open":0.4264,"high":0.4264,"low":0.4264,"amount":14187838.9336992,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"symbolChange":{"newSymbol":"LSTA","executeDate":"2022-09-15"},"adr":0,"adrRate":0,"listingDate":1186632000000,"exchange":"NASDAQ","adjPreClose":0.4264,"volumeRatio":0},"requestUrl":"/m/hq/s/CLBS","defaultTab":"news","newsList":[{"id":"2267485515","title":"Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2267485515","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2267485515?lang=en_us&edition=fundamental","pubTime":"2022-09-14 12:00","pubTimestamp":1663128000,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2022/09/14/2515879/18623/en/Caladrius-Biosciences-Announces-Approval-of-Merger-and-Name-Change-to-Lisata-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","CLBS","BK4139"],"gpt_icon":0},{"id":"2258210630","title":"Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2258210630","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2258210630?lang=en_us&edition=fundamental","pubTime":"2022-08-10 23:33","pubTimestamp":1660145587,"startTime":"0","endTime":"0","summary":"Here&#39;s a roundup of top developments in the biotech space over the last 24 hours:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/22/08/28436498/biotech-daily-cancer-causing-impurities-in-mercks-diabetic-drug-vir-bio-gsk-shun-fda-submission-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4559","KRTX","ARDS","MIRM","BK4516","ALPN","SABS","IBB","BK4139","BK4533","GMTX","BK4550","MRK","BMY","RHHBY","GSK","CNTA","CLBS","BCDA","TSVT","BK4568","GSK.UK","EVO","TCON","VIR","VRNA","BK4007","BK4548","BK4551","ADMP","ASND","VYNE","CYCC","AEMD","EYEN","BNTX","BK4535","BK4534","DMAC"],"gpt_icon":0},{"id":"2258215926","title":"BRIEF-Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement With Roche","url":"https://stock-news.laohu8.com/highlight/detail?id=2258215926","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2258215926?lang=en_us&edition=fundamental","pubTime":"2022-08-10 20:37","pubTimestamp":1660135025,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLBS","BK4139"],"gpt_icon":0},{"id":"2258218425","title":"Press Release: Caladrius Biosciences' Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2258218425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2258218425?lang=en_us&edition=fundamental","pubTime":"2022-08-10 20:00","pubTimestamp":1660132800,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLBS","BK4139"],"gpt_icon":0},{"id":"2257818769","title":"Caladrius Biosciences Q2 EPS $(0.11) Misses $(0.10) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2257818769","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2257818769?lang=en_us&edition=fundamental","pubTime":"2022-08-05 05:39","pubTimestamp":1659649155,"startTime":"0","endTime":"0","summary":"Caladrius Biosciences (NASDAQ:CLBS) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 10 percent decrease over losses of $(0.10) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/22/08/28366746/caladrius-biosciences-q2-eps-0-11-misses-0-10-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTWO","CLBS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.caladrius.com","stockEarnings":[{"period":"1week","weight":-0.9333},{"period":"1month","weight":-0.9333},{"period":"3month","weight":-0.9333},{"period":"6month","weight":-0.9333},{"period":"1year","weight":-0.9333},{"period":"ytd","weight":-0.9333}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; OLOGO, a regenerative medicine advanced therapy for treating no-option refractory disabling angina; CLBS16 that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.177961},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.04048},{"month":3,"riseRate":0.714286,"avgChangeRate":0.037181},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.124462},{"month":5,"riseRate":0,"avgChangeRate":-0.071523},{"month":6,"riseRate":0.571429,"avgChangeRate":0.077934},{"month":7,"riseRate":0.25,"avgChangeRate":-0.030099},{"month":8,"riseRate":0.125,"avgChangeRate":-0.064898},{"month":9,"riseRate":0.25,"avgChangeRate":-0.027192},{"month":10,"riseRate":0,"avgChangeRate":-0.145503},{"month":11,"riseRate":0.571429,"avgChangeRate":0.026317},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.124547}],"exchange":"NASDAQ","name":"Caladrius Biosciences","nameEN":"Caladrius Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caladrius Biosciences(CLBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Caladrius Biosciences(CLBS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Caladrius Biosciences,CLBS,Caladrius Biosciences股票,Caladrius Biosciences股票老虎,Caladrius Biosciences股票老虎国际,Caladrius Biosciences行情,Caladrius Biosciences股票行情,Caladrius Biosciences股价,Caladrius Biosciences股市,Caladrius Biosciences股票价格,Caladrius Biosciences股票交易,Caladrius Biosciences股票购买,Caladrius Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caladrius Biosciences(CLBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Caladrius Biosciences(CLBS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}